Percepción de los docentes sobre la aplicación del plan individual de ajustes razonables, en educación básica

The present project seeks to deepen the analysis, application, and relevance of the individual plan of reasonable adjustments in the academic improvement of children with special educational needs. This is related with the curriculum and the pedagogical processes, framed in the rationalist-deductive paradigm, with a mixed approach and with a type of descriptive design. A sample consisting of classroom and support teachers, students, parents and principals of the school Vista Hermosa de Soledad was taken as a source of analysis, to which surveys and interviews were applied, and all of them validated by experts. After processing and making the analysis of the information, it was possible to identify the gaps in the dissemination and application of the PIAR and it is seen as a weakness that all the responsibility lies on the support teachers; the interest shown by teachers in appropriating the processes of inclusion stands out. In the school, PIAR sensitization processes that allow the progress of academic processes must be generated. Finally, the project allowed to reveal the guidelines for the application of the PIAR in the institution.La presente investigación, buscó profundizar en el análisis, aplicación y relevancia del plan individual de ajustes razonables en el mejoramiento académico de los niños con necesidades educativas especiales. Se encuentra relacionada a la línea Currículo y Procesos Pedagógicos, enmarcada en el paradigma racionalista- deductivo, con un enfoque mixto y con un tipo de diseño descriptivo. Se tomó como fuente de análisis una muestra conformada por docentes de aula, docente de apoyo, estudiantes, padres de familia y directivos docentes de la Institución educativa Vista Hermosa de Soledad, a los cuales se les aplicaron encuestas y entrevistas, todas validadas por expertos. Después de procesar y hacer el respectivo análisis de la información se pudo identificar que existen vacíos en la difusión y aplicación del PIAR y se ve como debilidad que toda la responsabilidad esté sobre las docentes de apoyo; se destaca el interés de los docentes por apropiarse de los procesos de inclusión. Dentro de la escuela se deben generar procesos de sensibilización del PIAR que permitan el avance de los procesos académicos. Por último el trabajo permitió develar los lineamientos para la aplicación del PIAR en la institución

Uso de instrumentos clínicos para la evaluación de pacientes y resultados de tratamiento en trastornos por uso de sustancias (TUS)

Introducción. En la actualidad resulta imprescindible contar con instrumentos que permitan evaluar los resultados de tratamiento en pacientes con trastornos por uso de sustancias.Objetivo. Revisar la literatura científica de los últimos 10 años relacionada con la validación y el uso de instrumentos o de otros indicadores de resultado para la evaluación de tratamientos de trastornos por uso de sustancias.Materiales y métodos. Se realizó una búsqueda de artículos científicos publicados entre 2005 y 2015 que abordaran el tema de instrumentos de medida de los trastornos por uso de sustancias y la efectividad de los tratamientos. Se utilizó la base de datos MEDLINE y se limitó la búsqueda a títulos, resúmenes y textos completos disponibles.Resultados. Se seleccionaron 21 estudios de validación de instrumentos, 14 de evaluación de resultados utilizando instrumentos, 5 revisiones narrativas y 2 sistemáticas.Conclusiones. Los instrumentos encontrados exploran diferentes áreas según el tipo de tratamiento y los objetivos propuestos, sin embargo no hay una prueba única que permita evaluar de manera íntegra los resultados del tratamiento debido a la complejidad del tema. Se recomienda continuar con el desarrollo y validación de instrumentos específicos para tratamientos complejos en instituciones que trabajan con modelos terapéuticos integrales.Introduction: Having tools to assess the outcomes of treatment in patients with substance use disorders is highly important.Objective: To review the last 10 years of scientific literature related to the validation and use of instruments or other performance measures in treatment evaluation.Materials and methods: A search of scientific papers, published between 2005 and 2015, addressing measurement instruments for substance use disorders and effectiveness of treatments was performed. The MEDLINE database was used and the search was limited to titles, abstracts and full texts available.Results: 21 instrument validation studies, 14 performance evaluations using instruments, 5 narrative reviews and 2 systematic reviews were selected.Conclusions: The found instruments explore different areas depending on the type of treatment and proposed objectives; however, there is not a unique test to fully assess the results of treatment due to the complexity of the topic. It is recommended to continue the development and validation of specific tools for complex treatments in institutions working with comprehensive therapeutic models

Development and validation of Multimodal Scale for results of treatment in disorders caused by substance use

Objetivo: Describir el proceso de desarrollo y validación de un instrumento creado para la evaluación de los resultados de tratamiento en los trastornos por uso de sustancias. Materiales y métodos: Este fue llevado a cabo en tres fases. Fase 1: revisión de la literatura en las principales bases de datos de ciencias de la salud sobre escalas o instrumentos para evaluación de resultados de tratamiento en trastornos por uso de sustancias. Fase 2: desarrollo de un instrumento de novo y validación por expertos mediante técnica Delphi modificada a 2 fases. Fase 3: estudio de validación clínica en el que participaron 100 usuarios de una institución pública. Resultados: La escala de evaluación de tratamiento multimodal (EETM) obtuvo, luego de su análisis de contenido, unos resultados apropiados en términos de pertinencia y relevancia; adicionalmente mostró coeficientes de alpha de Cronbach entre 0,799 y 0,963 y similitudes entre los resultados del evaluador y el paciente. Conclusiones: Se concluye que la EETM demostró ser un instrumento válido para la evaluación de los resultados de tratamiento en instituciones con intervenciones integrales en los trastornos por uso de sustancias y durante el período de internamiento.Objective: to describe the process of development and validation of an instrument created for the evaluation of treatment results in disorders caused by substance use. Materials and methods: The study was carried out in three phases. Phase 1: review of the literature in the main health science databases about scales or instruments for evaluation of treatment results in disorders caused by substance use; Phase 2: de novo instrument development and validation by experts using a modified 2-phase Delphi technique; Phase 3: clinical validation study involving 100 users of a public institution. Results: The “Escala de evaluación de tratamiento multimodal” (EETM), after its content analysis, obtained appropriate results in terms of pertinence and relevance. Additionally, it showed Cronbach’s Alpha coefficients between 0.799 and 0.963 and similarities between the evaluator and the patient results. Conclusions: It was concluded that the EETM proved to be a valid instrument for the evaluation of treatment results in institutions with comprehensive interventions in disorders caused by substance use and during the admission period

Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations

Transcription disequilibria are characteristic of many neurodegenerative diseases. The activity-evoked transcription of immediate early genes (IEGs), important for neuronal plasticity, memory and behavior, is altered in CNS diseases and governed by epigenetic modulation. KDM1A, a histone 3 lysine 4 demethylase that forms part of transcription regulation complexes, has been implicated in the control of IEG transcription. Here we report the development of vafidemstat (ORY-2001), a brain penetrant inhibitor of KDM1A and MAOB. ORY-2001 efficiently inhibits brain KDM1A at doses suitable for long term treatment, and corrects memory deficit as assessed in the novel object recognition testing in the Senescence Accelerated Mouse Prone 8 (SAMP8) model for accelerated aging and Alzheimer's disease. Comparison with a selective KDM1A or MAOB inhibitor reveals that KDM1A inhibition is key for efficacy. ORY-2001 further corrects behavior alterations including aggression and social interaction deficits in SAMP8 mice and social avoidance in the rat rearing isolation model. ORY-2001 increases the responsiveness of IEGs, induces genes required for cognitive function and reduces a neuroinflammatory signature in SAMP8 mice. Multiple genes modulated by ORY-2001 are differentially expressed in Late Onset Alzheimer's Disease. Most strikingly, the amplifier of inflammation S100A9 is highly expressed in LOAD and in the hippocampus of SAMP8 mice, and down-regulated by ORY-2001. ORY-2001 is currently in multiple Phase IIa studies

Formation and emission properties of single InGaAs/GaAs quantum dots and pairs grown by droplet epitaxy

Trabajo presentado a la 30th International Conference on the Physics of Semiconductors, celebrada en Seul (Korea) del 25 al 30 de Julio de 2010.The emission properties of lateral and vertical QD pairs grown on GaAs nanoholes are investigated. Vertical QD pairs with different size asymmetry have been fabricated controlling the bottom QD size independently of the areal density. The emission of individual pairs is dominated by spectral diffusion effects and charge instabilities induced by the local charge environment. Lateral QD pairs have been fabricated on GaAs nanoholes and studied as a function of an electric field applied in the growth plane.Peer Reviewe

Modulation of KDM1A with vafidemstat rescues memory deficit and behavioral alterations

Transcription disequilibria are characteristic of many neurodegenerative diseases. The activity-evoked transcription of immediate early genes (IEGs), important for neuronal plasticity, memory and behavior, is altered in CNS diseases and governed by epigenetic modulation. KDM1A, a histone 3 lysine 4 demethylase that forms part of transcription regulation complexes, has been implicated in the control of IEG transcription. Here we report the development of vafidemstat (ORY-2001), a brain penetrant inhibitor of KDM1A and MAOB. ORY-2001 efficiently inhibits brain KDM1A at doses suitable for long term treatment, and corrects memory deficit as assessed in the novel object recognition testing in the Senescence Accelerated Mouse Prone 8 (SAMP8) model for accelerated aging and Alzheimer's disease. Comparison with a selective KDM1A or MAOB inhibitor reveals that KDM1A inhibition is key for efficacy. ORY-2001 further corrects behavior alterations including aggression and social interaction deficits in SAMP8 mice and social avoidance in the rat rearing isolation model. ORY-2001 increases the responsiveness of IEGs, induces genes required for cognitive function and reduces a neuroinflammatory signature in SAMP8 mice. Multiple genes modulated by ORY-2001 are differentially expressed in Late Onset Alzheimer's Disease. Most strikingly, the amplifier of inflammation S100A9 is highly expressed in LOAD and in the hippocampus of SAMP8 mice, and down-regulated by ORY-2001. ORY-2001 is currently in multiple Phase IIa studies

Endothelial C-type natriuretic peptide maintains vascular homeostasis

PMCID: PMC4151218Wellcome Trust (084449/Z/07/Z and 078496/Z/05/Z

Estudio para la implantación de Programas en Inglés en los títulos de grado de la ETSI Agrónomos de la Universidad Politécnica de Madrid

Universities are offering more and more courses and programmes in an additional language. At HEPCLIL, therefore, we would like to debate the methodological im - plications of these changes, giving voice to practical classroom experiences and initiatives. We would also like to act as a platform for cutting-edge research on CLIL in higher education. What impact does teaching in an additional language have on content or language learning? What are the effects on teachers and stu - dents in higher education

Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Background: Chronic anticoagulation with vitamin K antagonists (VKAs) is recommended in patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF). Direct oral anticoagulants (NOACs) are an alternative to VKAs but there are limited data to support their use in HCM. We sought to describe the pattern of use, thromboembolic events, bleeding and quality of life in patients with HCM and AF treated with NOACs. Methods: Data from patients treated with NOACs (n=99) and VKA (n=433) at 9 inherited cardiac diseases units were retrospectively collected. Annual rates of embolic events, serious bleeding and death were analysed and compared. Quality of life and treatment satisfaction were evaluated with SF-36 and SAFUCA questionnaires in 80 NOAC-treated and 57 VKA-treated patients. Results: After median follow-up of 63 months (IQR:26–109), thromboembolic events (TIA/stroke and peripheral embolism) occurred in 10% of patients on oral anticoagulation. Major/clinically relevant bleeding occurred in 3.8% and the global mortality rate was 23.3%. Thromboembolic event rate was 0.62 per 100 patient-years in the NOAC group vs. 1.59 in the VKA group [subhazard ratio (SHR) 0.32;95%CI:0.04– 2.45;p=0.27]. Major/clinically relevant bleeding occurred in 0.62 per 100 person-years in the NOAC group vs. 0.60 in the VKA group (SHR 1.28;95%CI 0.18–9.30;p=0.85). Quality of life scores were similar in both groups; however, NOAC-treated patients achieved higher scores in the SAFUCA. Conclusions: HCM patients with AF on NOACs showed similar embolic and bleeding rates to those on VKA. Although quality of life was similar in both groups, the NOAC group reported higher treatment satisfaction.pre-print929 K

Seroprevalence of Neospora caninum in non-carnivorous wildlife from Spain

Serum samples from 1034 non-carnivorous wildlife from Spain were tested for antibodies to Neospora caninum by competitive screening enzyme linked immunosorbent assay (ELISA) and confirmed by an indirect fluorescent antibody test (IFAT). High agreement was observed between results in both techniques (kappa value higher than 0.9). Prevalences of N. caninum antibodies positive by both techniques were 11.8% of 237 red deer (Cervus elaphus), 7.7% of 13 barbary sheep (Ammotragus lervia), 6.1% of 33 roe deer (Capreolus capreolus) and 0.3% of 298 wild boar (Sus scrofa). In one of 53 hares (Lepus granatensis), antibodies were found in the ELISA but could not be confirmed by IFAT due to lack of sample. Antibodies to N. caninum were not found in any of 251 wild rabbits (Oryctolagus cuniculus), 79 fallow deer (Dama dama), 27 mouflon (Ovis ammon), 40 chamois (Rupicapra pyrenaica) and three Spanish ibex (Capra pyrenaica). Statistically significant differences were observed between N. caninum seroprevalence in red deer and management of hunting estates (open versus fenced) with higher prevalence in fenced estates, and among sampling sites. Seroprevalence was particularly high in some areas (MO estate in South-Central Spain or some estates of Catalonia, North-East Spain), while no contact with N. caninum was observed in others. Results indicate that in certain areas of Spain, N. caninum is present in wildlife, especially in red deer. These results have important implications in both sylvatic cycles and may influence the prevalence of infection in cattle farms in those areas. To our knowledge, this is the first report of antibodies to N. caninum in wildlife from Spain and the first report of N. caninum antibodies in barbary sheep and wild boar.This is a contribution to the agreements between Yolanda Fierro and UCLM, CSIC, OAPN and SDGSA, Ministerio de Agricultura. Fran Ruiz-Fons received financial support through a grant from the Ministerio de Educación y Ciencia. This study received support from the Spanish CICYT, grant AGL2004-06103-C02-01/GAN and AGL2005-07401-CO3-01-GAN, Ministerio de Ciencia y Tecnología and FEDER.Peer reviewe